CanCan has developed an ultra-sensitive assay that is able to detect even the most minute amount of tumour DNA present in patients’ blood. The assay is similar to technologies used in human cancer diagnostics. We use next generation sequencing, a revolutionary technology that can efficiently decode DNA. This can be used for various purposes e.g: Identifying genetic variations, diagnosing diseases, monitoring disease progression.

We have made the choice of transparency. Below you will find extracts of our research papers, posters presented at conference, and other scientific presentations aimed at veterinary oncologists and practitioners.